vs
PROGRESS SOFTWARE CORP（PRGS）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
PROGRESS SOFTWARE CORP的季度营收约是再鼎医药的2.0倍（$252.7M vs $127.1M），PROGRESS SOFTWARE CORP同比增速更快（17.5% vs 17.1%），PROGRESS SOFTWARE CORP自由现金流更多（$59.9M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 17.0%）
Progress Software是全球领先的企业级软件服务商，主营应用开发平台、数据连接工具、数字体验解决方案等产品，服务覆盖金融、医疗、制造、零售等多行业的全球企业客户，助力客户搭建高性能可扩展的业务应用，提升运营效率。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
PRGS vs ZLAB — 直观对比
营收规模更大
PRGS
是对方的2.0倍
$127.1M
营收增速更快
PRGS
高出0.4%
17.1%
自由现金流更多
PRGS
多$86.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
17.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $252.7M | $127.1M |
| 净利润 | $25.7M | — |
| 毛利率 | 81.6% | 51.0% |
| 营业利润率 | 15.2% | -54.6% |
| 净利率 | 10.2% | — |
| 营收同比 | 17.5% | 17.1% |
| 净利润同比 | 2144.6% | — |
| 每股收益（稀释后） | $0.59 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGSZLAB
| Q4 25 | $252.7M | $127.1M | ||
| Q3 25 | $249.8M | $115.4M | ||
| Q2 25 | $237.4M | $109.1M | ||
| Q1 25 | $238.0M | $105.7M | ||
| Q4 24 | $215.0M | $108.5M | ||
| Q3 24 | $178.7M | $101.8M | ||
| Q2 24 | $175.1M | $100.1M | ||
| Q1 24 | $184.7M | $87.1M |
净利润PRGSZLAB
| Q4 25 | $25.7M | — | ||
| Q3 25 | $19.4M | $-36.0M | ||
| Q2 25 | $17.0M | $-40.7M | ||
| Q1 25 | $10.9M | $-48.4M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $28.5M | $-41.7M | ||
| Q2 24 | $16.2M | $-80.3M | ||
| Q1 24 | $22.6M | $-53.5M |
毛利率PRGSZLAB
| Q4 25 | 81.6% | 51.0% | ||
| Q3 25 | 81.0% | 59.5% | ||
| Q2 25 | 80.1% | 60.6% | ||
| Q1 25 | 80.6% | 63.6% | ||
| Q4 24 | 83.0% | 61.5% | ||
| Q3 24 | 83.7% | 64.1% | ||
| Q2 24 | 81.7% | 64.9% | ||
| Q1 24 | 82.2% | 61.4% |
营业利润率PRGSZLAB
| Q4 25 | 15.2% | -54.6% | ||
| Q3 25 | 17.6% | -42.3% | ||
| Q2 25 | 16.3% | -50.3% | ||
| Q1 25 | 13.6% | -53.3% | ||
| Q4 24 | 10.0% | -62.6% | ||
| Q3 24 | 22.6% | -66.6% | ||
| Q2 24 | 15.5% | -76.0% | ||
| Q1 24 | 19.0% | -80.7% |
净利率PRGSZLAB
| Q4 25 | 10.2% | — | ||
| Q3 25 | 7.8% | -31.2% | ||
| Q2 25 | 7.2% | -37.3% | ||
| Q1 25 | 4.6% | -45.8% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 15.9% | -40.9% | ||
| Q2 24 | 9.2% | -80.2% | ||
| Q1 24 | 12.3% | -61.4% |
每股收益（稀释后）PRGSZLAB
| Q4 25 | $0.59 | $-0.05 | ||
| Q3 25 | $0.44 | $-0.03 | ||
| Q2 25 | $0.39 | $-0.04 | ||
| Q1 25 | $0.24 | $-0.04 | ||
| Q4 24 | $0.01 | $-0.09 | ||
| Q3 24 | $0.65 | $-0.04 | ||
| Q2 24 | $0.37 | $-0.08 | ||
| Q1 24 | $0.51 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $94.8M | $689.6M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $478.3M | $715.5M |
| 总资产 | $2.5B | $1.2B |
| 负债/权益比越低杠杆越低 | 2.93× | — |
8季度趋势，按日历期对齐
现金及短期投资PRGSZLAB
| Q4 25 | $94.8M | $689.6M | ||
| Q3 25 | $99.0M | $717.2M | ||
| Q2 25 | $102.0M | $732.2M | ||
| Q1 25 | $124.2M | $757.3M | ||
| Q4 24 | $118.1M | $779.7M | ||
| Q3 24 | $232.7M | $616.1M | ||
| Q2 24 | $190.4M | $630.0M | ||
| Q1 24 | $133.2M | $650.8M |
总债务PRGSZLAB
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PRGSZLAB
| Q4 25 | $478.3M | $715.5M | ||
| Q3 25 | $477.7M | $759.9M | ||
| Q2 25 | $452.7M | $791.7M | ||
| Q1 25 | $431.8M | $810.8M | ||
| Q4 24 | $438.8M | $840.9M | ||
| Q3 24 | $425.6M | $667.7M | ||
| Q2 24 | $401.7M | $704.2M | ||
| Q1 24 | $461.7M | $762.2M |
总资产PRGSZLAB
| Q4 25 | $2.5B | $1.2B | ||
| Q3 25 | $2.4B | $1.2B | ||
| Q2 25 | $2.4B | $1.2B | ||
| Q1 25 | $2.5B | $1.2B | ||
| Q4 24 | $2.5B | $1.2B | ||
| Q3 24 | $1.6B | $985.3M | ||
| Q2 24 | $1.6B | $987.4M | ||
| Q1 24 | $1.5B | $988.4M |
负债/权益比PRGSZLAB
| Q4 25 | 2.93× | — | ||
| Q3 25 | 2.97× | — | ||
| Q2 25 | 3.22× | — | ||
| Q1 25 | 3.50× | — | ||
| Q4 24 | 3.48× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.8M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $59.9M | $-26.7M |
| 自由现金流率自由现金流/营收 | 23.7% | -21.0% |
| 资本支出强度资本支出/营收 | 1.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.44× | — |
| 过去12个月自由现金流最近4个季度 | $229.5M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流PRGSZLAB
| Q4 25 | $62.8M | $-26.0M | ||
| Q3 25 | $73.4M | $-32.0M | ||
| Q2 25 | $30.0M | $-31.0M | ||
| Q1 25 | $68.9M | $-61.7M | ||
| Q4 24 | $19.7M | $-55.8M | ||
| Q3 24 | $57.7M | $-26.8M | ||
| Q2 24 | $63.7M | $-42.2M | ||
| Q1 24 | $70.5M | $-90.1M |
自由现金流PRGSZLAB
| Q4 25 | $59.9M | $-26.7M | ||
| Q3 25 | $72.4M | $-35.0M | ||
| Q2 25 | $29.5M | $-33.9M | ||
| Q1 25 | $67.7M | $-63.2M | ||
| Q4 24 | $16.8M | $-58.4M | ||
| Q3 24 | $56.6M | $-28.2M | ||
| Q2 24 | $62.7M | $-42.9M | ||
| Q1 24 | $70.2M | $-91.1M |
自由现金流率PRGSZLAB
| Q4 25 | 23.7% | -21.0% | ||
| Q3 25 | 29.0% | -30.4% | ||
| Q2 25 | 12.4% | -31.1% | ||
| Q1 25 | 28.4% | -59.9% | ||
| Q4 24 | 7.8% | -53.8% | ||
| Q3 24 | 31.7% | -27.7% | ||
| Q2 24 | 35.8% | -42.9% | ||
| Q1 24 | 38.0% | -104.5% |
资本支出强度PRGSZLAB
| Q4 25 | 1.1% | 0.5% | ||
| Q3 25 | 0.4% | 2.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.5% | 1.5% | ||
| Q4 24 | 1.3% | 2.4% | ||
| Q3 24 | 0.6% | 1.3% | ||
| Q2 24 | 0.5% | 0.7% | ||
| Q1 24 | 0.2% | 1.1% |
现金转化率PRGSZLAB
| Q4 25 | 2.44× | — | ||
| Q3 25 | 3.78× | — | ||
| Q2 25 | 1.76× | — | ||
| Q1 25 | 6.30× | — | ||
| Q4 24 | 17.13× | — | ||
| Q3 24 | 2.03× | — | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | 3.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
